TSX:GUD (Knight Therapeutics Inc.)

About GUD

Knight Therapeutics Inc is a specialty and generic drug manufacturing company. The company's principal business activity is focused on developing, acquiring, in-licensing, out-licensing, marketing, and distributing innovative pharmaceutical products, consumer health products, and medical devices in Canada and select international markets. Knight finances other life sciences companies across the globe in order to generate interest income, strengthen relationships in the life sciences industry, and to secure product distribution rights.
  • Knight Therapeutics Inc. (TSX: GUD) Latest News

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    4 Biotech Stocks That Could Break Through the Market

    Four TSX biotech stocks could deliver outsized gains in 2023, as they are poised to break through the market soon.

    Read more »

    lab worker inspects test tubes
    Dividend Stocks

    3 Biotech Stocks to Buy Before the Down Market Is Over

    Biotech stocks are high-risk, high-reward investments, although three names are buying opportunities in the current down market.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    This Biotech Stock Could Offer Big Growth – Even During a Recession

    Here's why Knight Therapeutics (TSX:GUD) is one biotech stock that's worth a buy, or at least a look, in this…

    Read more »

    pharma, vaccine, coronavirus, COVID
    Stocks for Beginners

    2 Health Care Stocks Could Return at Least 50% in 1 Year

    The health care sector continues to underperform, although two stocks could deliver superior returns in one year.

    Read more »

    healthcare pharma
    Investing

    Can the Healthcare Sector Rebound in 2022?

    Despite the overall downfall of the healthcare sector (weighed down by marijuana companies), there are stocks that might display strong…

    Read more »

    healthcare pharma
    Investing

    Strong Buy Ratings: 2 Healthcare Stocks With More Than 40% Upside

    The healthcare sector has two constituents that could deliver more than 40% in capital gains. Invest in WELL Health Technologies…

    Read more »

    Test tubes
    Coronavirus

    Forget Trillium Therapeutics Stock (TSX:TRIL): Buy These Pharma Stocks Instead!

    Motley Fool investors who want in on a pharma rebound should definitely look into these stocks over Trillium Therapeutics stock…

    Read more »

    Hand arranging wood block stacking as step stair with arrow up.
    Investing

    TFSA Investors: 1 Low-Risk Value Stock With Significant Upside

    Knight Therapeutics Inc. (TSX:GUD) is focused on building a portfolio of innovative products through in-licensing or acquiring product rights.

    Read more »

    Profit dial turned up to maximum
    Coronavirus

    Got $3,000? 3 Dirt-Cheap TSX Stocks to Buy Today

    Canadians who are looking to splurge in September should look to oversold TSX stocks like Knight Therapeutics Inc. (TSX:GUD).

    Read more »

    Businessperson's Hand Putting Coin In Piggybank
    Dividend Stocks

    TFSA: 3 Super Stocks That Can Make You Rich

    Top healthcare stocks like Savaria Corporation (TSX:SIS) have huge potential, which is why TFSA investors should target them today.

    Read more »

    edit Woman in skates works on laptop
    Investing

    Top TSX Stocks Under $10

    Markets have been somewhat volatile to close out this month, so investors should target TSX stocks that are on the…

    Read more »

    Test tubes
    Coronavirus

    2 TSX Pharma Stocks That Can Make You a TFSA Millionaire

    Here's why you can buy shares of Viemed Healthcare and Knight Therapeutics right now!

    Read more »